TF and atherosclerosis: Not only have TF+ MP been found to contribute to clot propagation in preclinical models16, 17, 18, but numbers of circulating TF+ MP have been related to clinical thrombosis in sepsis, atherosclerosis, malignancy and venous thromboembolism19, 20, 21, 22.